Announced Mon, 29 Sept · 10:45 IST

Proceeding of Annual General Meeting

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Rekvina Laboratories Limited held its 37th AGM on September 26, 2025, at 2:30 PM in Vadodara, Gujarat. The meeting was chaired by Managing Director Amit Shah, with 16 members present representing 2,904,831 equity shares (48.19% quorum). Three items were transacted: adoption of audited financial statements for FY ended March 31, 2025, re-appointment of Mrs. Ilaben Pathak as Director (retiring by rotation), and appointment of the Secretarial Auditor for five years. The auditor's report was clean with no qualifications, observations, or adverse remarks. Voting was conducted via remote e-voting (CDSL) and ballot at the venue, with results to be declared within the prescribed time.

Likely market impact

This is a routine regulatory filing confirming that standard AGM items were completed. The clean auditor's report and approval of financial statements are positive procedural signals, but the document itself contains no new material business information or strategic announcements that would materially move the stock price.